Skip to main content
MHUAF logo

MHUAF · Meihua International Medical Technologies Co., Ltd.

$8.77 +0.00 (+0.00%) At close · Jul 29
Market Cap
$7.50M
Shares
855,595

Price & Indicators

20d MA 50d MA 200d MA Earnings Filing Insider Congress Investor day
Close$8.77 Open$8.77 Day$8.77–8.77 52W$2.05–50.00 Avg vol 30d203 Short int1K · 0.2% float · 3.3d Short vol1% DataFeb 2022–Jul 2026

Up next

FQ3-26 quarter ends
~Sep 30, 2026 Est

Equibles Rating

blended score · not investment advice
Overall
Sell
SellHoldBuy
Technical Sell Momentum Weak Sentiment Neutral Fundamentals Fair Quant / Vol High
Market backdrop VIX 20.7 · elevated Equity put/call 0.61
Technical
price trend
Sell
50 / 200-day cross No cross
Price vs 200-day avg −20%
below
Price vs 50-day avg +2%
above
RSI (14) 56
neutral
MACD trend Negative
52-week position 14%
near low
Momentum
relative strength
Weak
1-month return −1%
trailing
6-month return −21%
trailing
YTD return +328%
this year
Relative strength −28%
vs S&P · 6-mo
Sentiment
smart money
Neutral
Trend (MA cross) No cross
50d $9 › 200d $11 — 200d above 50d
Institutional flow Flat
No 13F holder data
Insider flow Flat
No net insider activity over 90 days
Short interest Falling
0.16% of float · ▼ -4.1% MoM · 3.3 days cover
Volume signal Normal
Volume near normal
Institution breadth Steady
No 13F holder history
Squeeze score 35
low risk · 0–100
Fundamentals
Fair
Revenue growth −36%
Y/Y
Gross margin 31%
contracting
EPS growth −54%
Y/Y
Free cash flow $554.3K
Balance sheet $16.2M
net cash
Quant / Vol
risk profile
High
Volatility 130%
annualized · 1-yr
Max drawdown −96%
past year
ATR 0.9%
of price · 14-day

Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.

Technicals

trend & momentum for long-term holders Sell
3 · 2 · 1
50 / 200-day cross
No cross Neutral
Price vs 200-day avg
−20% Bearish
Price vs 50-day avg
+2% Bullish
RSI (14)
56 Neutral
MACD trend
Negative Bearish
52-week position
14% Bearish
Market signals — smart money & positioning
Bullish · 1 of 6
Trend (MA cross) No cross
50d $9 › 200d $11 — 200d above 50d
Institutional flow Flat
No 13F holder data
Insider flow Flat
No net insider activity over 90 days
Short interest Falling
0.16% of float · ▼ -4.1% MoM · 3.3 days cover
Volume signal Normal
Volume near normal
Institution breadth Steady
No 13F holder history
Price context
position in its 52-week range
52-wk low $2 Now $9 · 14% 52-wk high $50
vs 200-day avg -20% vs 50-day avg +2%

Illustrative technical + ownership context — a signal mix, not investment advice.

Versus peers

Medical Instruments & Supplies — same industry group
Open screener →
Company Mkt cap YTD Rev growth Y/Y P/E Short % shares
MHUAF
Meihua International Medical Technologies Co., Ltd.
this stock
$7.50M +327.8% -0.7% 0.2%
ISRG
Intuitive Surgical Inc
$124.74B -37.7% +20.5% 40.5 1.9%
MDLN
Medline Inc.
$51.06B -4.6% +11.5% 2.2%
BDX
Becton Dickinson & Co
$46.40B +11.9% +8.2% 64.0 3.8%
ALC
Alcon Inc
$33.96B -11.6% +10.5% 2.7%

Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding

At a glance

key data from every section
Short & Settlement
Short Interest Falling
Shares short
1.4K
Days to cover
3.3d
Change
-58 sh
View
Short Volume
Short vol %
1%
As of
Jul 28, 2026
Short Total
View
Fails to Deliver
FTD shares
1
Value
$8
As of
May 13, 2026
View
Off-Exchange
Off-exchange %
100.0%
Week of
May 4, 2026
Off-exch Lit
View
Financials
Financials
Revenue (FY)
$61.8M
Net income (FY)
$6.8M
EPS diluted
$18.04
View
Buybacks
Authorized
shares 159.4K
View
Filings
SEC Filings
Latest
6-K
Filed
Jun 26, 2026
This year
6
View
Exempt Offerings
Offering
$47.0M
Filed
Jan 8, 2024
View

Performance

5D 20D 120D MTD YTD
MHUAF +0.0% -1.5% -21.4% -1.5% +327.8%
SPY -2.4% -2.3% +6.3% -2.3% +7.0%
vs SPY +2.4% +0.9% -27.7% +0.9% +320.8%

Capital returns

Buyback program · as of Nov 8, 2025
Authorized
shares 159,350
Spent (derived)
Remaining

Dividends per share over the trailing 365 days by ex-date · buyback figures as last reported in SEC filings ("spent" derived as authorized − remaining; when several programs run concurrently, authorized is their combined total per the newest filing) · components shown separately — trailing-year buyback spend isn't tracked, so no combined shareholder yield is derived.

Key facts CIK 1835615 CUSIP G5966G116